A Study to Understand the Effect of a Study Medicine Called ARV-471 on Dabigatran Etexilate in Healthy Adults
An Interventional, Phase 1, Open-Label, Fixed-Sequence, 2-Period Study to Evaluate the Effect of a Single Oral Dose of ARV-471 (PF-07850327) on the Pharmacokinetics of Dabigatran in Healthy Participants
Category & Conditions: Cancer
Medicine: VEPDEGESTRANT
ClinicalTrials.gov Identifier (NCT): NCT05673889
Protocol ID: C4891008
Open Plain Language Summary Result:
Click here